Israel - inglés - Ministry of Health

bayer israel ltd - cyproterone acetate - tablets - cyproterone acetate 10 mg - cyproterone - cyproterone - treatment of pronounced signs of virilisation in women, which make hormone therapy necessary:• severe forms of acne, when it is accompanied by inflammation and the formation of nodes (acne papulopustulosa, acne nodulocystica) or if there is a risk of scarring,• moderate to severe forms of hirsutism,• moderate to severe forms of androgenic alopecia.cyproterone acetate 10 mg is indicated for pronounced signes of virilisation in women, which make hormone therapy necessary if satisfactory results could not be obtained with medicinal products containing low-dose cyproterone or with other treatment options. when treating acne, hormone treatment should be weighed against systemic antibiotic treatment

Malta - inglés - Medicines Authority

beecham group plc 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - aluminium chloride, hexahydrate - cutaneous solution - aluminium chloride hexahydrate 20 % (w/w) - other dermatological preparations

Australia - inglés - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - phosphine from aluminium phosphide - tablet (inc. pellet, bolus, suppository, capsule) - phosphine from aluminium phosphide gas active 330.0 g/kg - insecticide

Australia - inglés - APVMA (Australian Pesticides and Veterinary Medicines Authority)

titan ag pty ltd - phosphine (ph3) present as aluminium phosphide - sachet - phosphine (ph3) present as aluminium phosphide gas active 330.0 g/kg - insecticide

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

vetoquinol ireland limited - aluminium - cutaneous spray, powder - 4 percent weight/weight - aluminium agents - cats, cattle, dogs, horses, other birds, pigs, sheep - antibacterial

Australia - inglés - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - abacavir sulfate, quantity: 702 mg (equivalent: abacavir, qty 600 mg); lamivudine, quantity: 300 mg; dolutegravir, quantity: 50 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; povidone; magnesium stearate; purified water; mannitol; titanium dioxide; purified talc; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - trelavue is indicated for the treatment of human immunodeficiency virus (hiv) infection in adults and adolescents from 12 years of age who are antiretroviral treatment-na?ve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents (dolutegravir, abacavir or lamivudine) in trelavue.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - clopidogrel hydrogen sulfate -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - clopidogrel hydrogen sulfate -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - clopidogrel hydrogen sulfate -

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - ferrous sulfate dried - oral tablet - 200mg